Manufacturer record
L.V. Life Sciences: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by L.V. Life Sciences (Himachal Pradesh) were declared Not of Standard Quality between January 2023 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
6 records linked to L.V. Life Sciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Aceclofenac & Paracetamol Tablets | LV25DT-066BMfg 2025-04 · Exp 2027-03 | MisbrandadMisbranded | SDTL, ChhattisgarhState lab | May 2026 |
| Ovocet-M (Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP) | LV24MT-048CMfg 2024-12 · Exp 2026-11 | Test for Dissolution of Montelukast onlyDissolution | DTL, Bengaluru, KarnatakaState lab | Oct 2025 |
| Rabeprazole Sodium Gastro- resistant & Domperidone (SR) Capsules (Rebtil-DSR) | LV23LC-017Mfg 2023-11 · Exp 2025-10 | The sample does not conform to the claim with respect to Assay of Rabeprazole Sodium.Assay | DTL,Bikaner (State Lab)State lab | May 2025 |
| Calcium Carbonate and Vitamin D3 Tablets IP (Calimed Tablets) | LV22HT-863Mfg 2022-08 · Exp 2024-01 | Assay of Vitamin D3Assay | RDTL ChandigarhState lab | Oct 2023 |
| Levocetirizine Dihydrochloride Tablets IP (Svlo Tablets) | LV20MT-672Mfg 2020-12 · Exp 2022-11 | AssayAssay | RDTL ChandigarhState lab | Apr 2023 |
| Lvcipro-500 (Ciprofloxacin Hydrochloride Tablets IP) | LV22CT-691Mfg 2022-03 · Exp 2024-02 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.